Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Pharmaceutical Research
|
July 19, 2008
Including information on the therapeutic window in bioequivalence acceptance
Tom Jacobs, Filip De Ridder, Sarah Rusch, et al.
The Journal of Antimicrobial Chemotherapy
|
June 23, 2012
Replication capacity of minority variants in viral populations can affect the assessment of resistance in HCV chimeric replicon phenotyping assays
Thierry Verbinnen, Tom Jacobs, Leen Vijgen, et al.
Journal of Alzheimer'S Disease : JAD
|
August 17, 2013
Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model
Herman Borghys, Tom Jacobs, Bianca Van Broeck, et al.
Stroke
|
November 4, 2006
Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary
John Hallenbeck, Gregory Del Zoppo, Tom Jacobs, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 10, 2007
Localized activation of p21-activated kinase controls neuronal polarity and morphology
Tom Jacobs, Frédéric Causeret, Yoshiaki V Nishimura, et al.
Health Promotion Practice
|
August 30, 2018
Identifying Implementation Science Characteristics for a Prenatal Oral Health eHealth Application
Cheryl A Vamos, Shana M Green, Stacey Griner, et al.
Pharmaceutical Statistics
|
April 2, 2019
Bayesian sequential integration within a preclinical pharmacokinetic and pharmacodynamic modeling framework: Lessons learned
Fabiola La Gamba, Tom Jacobs, Helena Geys, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
August 15, 2008
The p21-activated kinase is required for neuronal migration in the cerebral cortex
Frédéric Causeret, Mami Terao, Tom Jacobs, et al.
Translational Behavioral Medicine
|
March 22, 2014
Minimal intervention needed for change: definition, use, and value for improving health and health research
Russell E Glasgow, Lawrence Fisher, Lisa A Strycker, et al.
British Journal of Clinical Pharmacology
|
January 17, 2007
The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males
Maria Laura Sargentini-Maier, Paul Rolan, John Connell, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Pharmaceutical Research
|
July 19, 2008
Including information on the therapeutic window in bioequivalence acceptance
Tom Jacobs, Filip De Ridder, Sarah Rusch, et al.
The Journal of Antimicrobial Chemotherapy
|
June 23, 2012
Replication capacity of minority variants in viral populations can affect the assessment of resistance in HCV chimeric replicon phenotyping assays
Thierry Verbinnen, Tom Jacobs, Leen Vijgen, et al.
Journal of Alzheimer'S Disease : JAD
|
August 17, 2013
Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model
Herman Borghys, Tom Jacobs, Bianca Van Broeck, et al.
Stroke
|
November 4, 2006
Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary
John Hallenbeck, Gregory Del Zoppo, Tom Jacobs, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 10, 2007
Localized activation of p21-activated kinase controls neuronal polarity and morphology
Tom Jacobs, Frédéric Causeret, Yoshiaki V Nishimura, et al.
Health Promotion Practice
|
August 30, 2018
Identifying Implementation Science Characteristics for a Prenatal Oral Health eHealth Application
Cheryl A Vamos, Shana M Green, Stacey Griner, et al.
Pharmaceutical Statistics
|
April 2, 2019
Bayesian sequential integration within a preclinical pharmacokinetic and pharmacodynamic modeling framework: Lessons learned
Fabiola La Gamba, Tom Jacobs, Helena Geys, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
August 15, 2008
The p21-activated kinase is required for neuronal migration in the cerebral cortex
Frédéric Causeret, Mami Terao, Tom Jacobs, et al.
Translational Behavioral Medicine
|
March 22, 2014
Minimal intervention needed for change: definition, use, and value for improving health and health research
Russell E Glasgow, Lawrence Fisher, Lisa A Strycker, et al.
British Journal of Clinical Pharmacology
|
January 17, 2007
The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males
Maria Laura Sargentini-Maier, Paul Rolan, John Connell, et al.
Page
of 9